Blood Glucose Meters (BGM) measure glucose levels at a single moment in time, while Continuous Glucose Monitoring (CGM) systems continually check glucose levels throughout the day and night.
Unlike a blood glucose meter (BGM), which provides just a single glucose reading. CGM systems can provide real-time, dynamic glucose information every five minutes.
Looking for helpful diabetes resources? Review our list of contact information for national organizations committed to helping those with diabetes, and their families, find support and guidance.
Dexcom announced today that due to the public health crisis of COVID-19 and the need to preserve personal protective equipment and reduce the frequency of hospital staff exposure to the coronavirus, the company is making its Dexcom G6 CGM System temporarily available for remote patient monitoring in the hospital setting. This decision was made based on feedback received from the U.S. Food and Drug Administration (FDA).
Dexcom, Inc. announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for healthcare professionals to use with their patients, ages two years and up.
DexCom Inc., a leader in continuous glucose monitoring (CGM), announced today that it is now accepting orders for the Dexcom G6 CGM System for people with diabetes ages two years and up.